Work

Characterization and first-in-human data of CLR457, an orally bioavailable pan-class I PI3-Kinase inhibitor

Year: 2018

Type: article

Study design: Clinical Trial

Authors: James J. Harding, Todd M. Bauer, Daniel Shao-Weng Tan, Philippe L. Bédard, Jordi Rodón, Toshihiko Doi, Christian Schnell, Varsha Iyer, Fabienne Baffert, Rajkumar Radhakrishnan, Claire Fabre, Dejan Juric

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3018719236

FWCI:

Cites:

Cited by:

Related to: 20